Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Rivaroxaban |
Synonyms | |
Therapy Description |
Rivaroxaban is a coagulation factor Xa inhibitor that prevents clot formation (PMID: 27161723). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Rivaroxaban | Xarelto | BAY 59-7939 | Rivaroxaban is a coagulation factor Xa inhibitor that prevents clot formation (PMID: 27161723). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02555878 | Phase III | Rivaroxaban | A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants | Completed | USA | GBR | FRA | DEU | CZE | CAN | BRA | BGR | BEL | 1 |